Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/biology9110374 http://scihub22266oqcxt.onion/10.3390/biology9110374 33153065!7692042!33153065     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biology+(Basel) 2020 ; 9 (11): ä Nephropedia Template TP {{tp|p=33153065|t=2020. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients |pdf=|usr=}}{{33153065}} gab.com Text Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients JO: Biology (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33153065 #FOAvip The pandemic virus SARS-CoV-2 has been reported to be able to enter the body via the eye conjunctiva, but the presence of antiviral response in the eye remains poorly known. Our study was thus aimed to analyze the presence of secretory mucosal anti-SARS-CoV-2 type A immunoglobulins (IgA) in the conjunctival fluid of COVID-19 patients. The tears of 28 COVID-19 patients and 20 uninfected controls were collected by the Schirmer test and analyzed by a specific ELISA assay detecting anti-spike (S1) virus protein IgA. The results showed that 35.7% of COVID-19 subjects have specific antiviral IgA at the ocular level, persisting till 48 days post disease onset. Most of the IgA positive subjects presented mild symptoms. The collected data indicate a prolonged persistence of anti-SARS-CoV-2 IgA at the eye level and suggest that IgA detection may be extremely helpful in clarifying virus pathology and epidemiology. Twit Text FOAVip Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients ????Biology (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33153065 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33153065 #FOAvip English Wikipedia <ref>{{Cite pmid|33153065}}</ref> Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients #MMPMID33153065 Caselli E; Soffritti I; Lamberti G; D'Accolti M; Franco F; Demaria D; Contoli M; Passaro A; Contini C; Perri P Biology (Basel) 2020[Nov]; 9 (11): ä PMID33153065show ga The pandemic virus SARS-CoV-2 has been reported to be able to enter the body via the eye conjunctiva, but the presence of antiviral response in the eye remains poorly known. Our study was thus aimed to analyze the presence of secretory mucosal anti-SARS-CoV-2 type A immunoglobulins (IgA) in the conjunctival fluid of COVID-19 patients. The tears of 28 COVID-19 patients and 20 uninfected controls were collected by the Schirmer test and analyzed by a specific ELISA assay detecting anti-spike (S1) virus protein IgA. The results showed that 35.7% of COVID-19 subjects have specific antiviral IgA at the ocular level, persisting till 48 days post disease onset. Most of the IgA positive subjects presented mild symptoms. The collected data indicate a prolonged persistence of anti-SARS-CoV-2 IgA at the eye level and suggest that IgA detection may be extremely helpful in clarifying virus pathology and epidemiology. äAnti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients (epmc).pdf DeepDyve Pubget Overpricing